Levoxyl (levothyroxine sodium tablets, USP) tablets 112 mcg, 100-count bottle, Rx Only,Distributed by Pfizer Inc. New York, NY 10017, NDC 60793-855-01
Published December 26, 2018 · Recall initiated: December 6, 2018
Summary
FDA records drug Class II recall D-0339-2019, published December 26, 2018 and initiated December 6, 2018. Recalling firm: Pfizer Inc.; Status: Terminated; Reported quantity: 1996 bottles; Lot: Lot #:18A18, Exp. 01/2020. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.
Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
Superpotent Drug.
What to do
Voluntary: Firm initiated · Letter
Get an email if LEVOXYL has another recall
Free. We only write when there's a new recall that matches. Unsubscribe in one click.
Recall details
- Brand
- LEVOXYL
- Manufacturer
- Pfizer Inc.
- Distributor
- Nationwide within the United States
- UPC
- 0360793856018
- Lot
- Lot #:18A18, Exp. 01/2020
- Risk classification
- Class II
- Area (FDA)
- drug
- Country
- United States
Related recalls
- FDALevoxyl (levothyroxine sodium tablets, USP), tablets, 175 mcg, 100 tablet bottle, Rx only, Distributed byOctober 28, 2026
- FDALevoxyl (levothyroxine sodium tablets, USP), tablets, 175 mcg, 1000-count bottle, Rx only, Distributed byOctober 28, 2026
- FDALevoxyl (levothyroxine sodium tablets, USP), 50 mcg, 100-count bottle, Rx only, Distributed by: Pfizer Inc.,August 20, 2025
- FDALEVOXYL Tablets, USD, 150MCG, 100-count bottle, Rx Only, Distributed by Pfizer Inc., New York, NY 10017, MADEJune 2, 2021
- FDAInfants' Ibuprofen, Concentrated Ibuprofen Oral Suspension, USP, (NSAID), 50 mg per 1.25 mL, Dye Free,December 26, 2018
- FDAAdvanced Protection Sunscreen spf 30 (Octinoxate 7.5%, Octisalate 5%, Oxybenzone 6%), 4.5 Oz/127.5 g tube.December 26, 2018
Questions about this recall
Was Levoxyl (levothyroxine sodium tablets, USP) tablets 112 mcg, 100-count bottle, Rx Only,Distributed by Pfizer Inc. New York, NY 10017, NDC 60793-855-01 recalled?
Yes. FDA published recall D-0339-2019 on December 26, 2018. Reported hazard: Superpotent Drug.
What should I do if I have this product?
Voluntary: Firm initiated · Letter
How do I know if my unit is part of the recall?
Compare your product details with the notice. Brand: LEVOXYL. UPC: 0360793856018.